Add BrightSurf on Google Email

University of California - San Diego


Educating community research facilitators helps protect integrity of study results

A recent study by University of California, San Diego School of Medicine reports that educating Community Health Workers (CHWs) and other 'citizen scientists' can boost the integrity of scientific research. The Building Research Integrity and Capacity (BRIC) program uses eight modules to teach research ethics and concepts.

SourceUniversity of California - San Diego·JournalJournal of Microbiology and Biology Education·DateMar 18, 2016

New therapy could treat poor blood circulation caused by peripheral artery disease

Researchers at the University of California, San Diego have developed a potential new therapy for critical limb ischemia, a condition that causes extremely poor circulation in the limbs. The therapy, an injectable gel derived from skeletal muscle tissue, promotes muscle remodeling and improves blood flow in a rat model.

SourceUniversity of California - San Diego·JournalJournal of the American College of Cardiology·DateMar 8, 2016

Engineers 3-D-print a new lifelike liver tissue for drug screening

A team of engineers at the University of California, San Diego has successfully created a 3D-printed liver tissue model that closely mimics human liver structure and function. The new model can be used for patient-specific drug screening and disease modeling, potentially saving pharmaceutical companies time and money.

SourceUniversity of California - San Diego·JournalProceedings of the National Academy of Sciences·DateFeb 8, 2016

Brain monitoring takes a leap out of the lab

A wearable, 64-channel brain monitoring system has been developed, providing a better fit for real-world applications. The system comprises a dry-electrode wearable EEG headset and sophisticated software for data interpretation, with a wide range of applications in research, neuro-feedback, and clinical diagnostics.

SourceUniversity of California - San Diego·JournalIEEE Transactions on Biomedical Engineering·DateJan 12, 2016

Discovery of an embryonic switch for cancer stem cell generation

Researchers at UC San Diego School of Medicine discovered a specific group of proteins decrease, triggering changes in the cancer microenvironment and accelerating growth of therapy-resistant CSCs. A targeted monoclonal antibody treatment effectively impaired CSC regeneration and made them easier to target with existing therapies.

SourceUniversity of California - San Diego·JournalProceedings of the National Academy of Sciences·DateNov 30, 2015